Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3

Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3

IntroductionNeuroendocrine neoplasms (NEN) are a rare and heterogenous group of tumors arising from neuroendocrine cells in multiple organs. Neuroendocrine tumors (NET) G3 encompass a small subgroup accounting for less than 10% of all neuroendocrine neoplasms. In contrast to NET G1 and G2 as well as...

Full description

Bibliographic Details
Main Authors: Martina Hinterleitner, Ruben Pfeiffer, Nils F. Trautwein, Bence Sipos, Stephan Singer, Silvio Nadalin, Alfred Königsrainer, Ulrich M. Lauer, Christian la Fougère, Lars Zender, Clemens Hinterleitner
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Endocrinology
Subjects:
neuroendocrine tumor
grading
G3
somatostatin receptor
PET
treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1285529/full

Similar Items

Similar Items